A
RCUS icon

AlphaQuest’s Arcus Biosciences RCUS Stock Holding History

AlphaQuest’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,300
Closed -$174K – 1606
2025
Q4 		$174K Buy
7,300
+3,349
+85% +$68.3K 0.01% 1516
2025
Q3 		$53.7K Sell
3,951
-11,815
-75% -$123K ﹤0.01% 1911
2025
Q2 		$128K Buy
15,766
+9,370
+146% +$80K 0.01% 1341
2025
Q1 		$50.2K Sell
6,396
-1,009
-14% -$11.7K 0.01% 1529
2024
Q4 		$110K Sell
7,405
-2,026
-21% -$33.1K 0.01% 1067
2024
Q3 		$144K Buy
9,431
+9,408
+40,904% +$148K 0.01% 1193
2024
Q2 		$350 Buy
23
+1
+5% +$16 ﹤0.01% 1438
2024
Q1 		$415 Sell
22
-3,991
-99% -$69K ﹤0.01% 1552
2023
Q4 		$76.6K Buy
+4,013
New +$64.1K 0.02% 816

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

AlphaQuest's RCUS Position: Q1 2026 in Review

AlphaQuest sold out of Arcus Biosciences (RCUS) in Q1 2026, closing a stake of 7,300 shares — an estimated $174K sold.

AlphaQuest first reported a position in RCUS in Q4 2023 and held it in 9 quarters. The position peaked at $174K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • AlphaQuest reported no remaining Arcus Biosciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 7,300 Arcus Biosciences shares in Q1 2026, an estimated $174K.
  • AlphaQuest first reported a position in Arcus Biosciences in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Arcus Biosciences position peaked at $174K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.